Yes, but the AUA already specifically mentioned them in their excellent submission on behalf of PEB to Novitas last time, see below:
https://api.nzx.com/public/announcement/417969/attachment/402704/417969-402704.pdf
I hope it goes well for PEB & they're successful this time, but I think I'll wait until they are actually approved before reinvesting as I lost too much money taking a punt based on the AUA submission linked above last time.
Ann: Cxbladder Incorporated into AUA Clinical Guideline, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.95M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2362 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 10865 | 2 |
View Market Depth
| Last trade - 09.59am 26/06/2025 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable